Goldman Sachs Group Inc Enochian Biosciences Inc Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 594,988 shares of ENOB stock, worth $2.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
594,988
Previous 182,054
226.82%
Holding current value
$2.74 Million
Previous $837,000
226.88%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ENOB
# of Institutions
46Shares Held
15.6MCall Options Held
107KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.92MShares$22.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.15MShares$9.89 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$4.67 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY893KShares$4.11 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...